Pharmaceutical

Pfizer gets grant for treatment of cancer using engineered immune cells targeting bcma

Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method for treating cancer. Learn about the unique ligand-binding and signaling domains for effective treatment.

Apr 25, 2024 - 00:00
Discover how Pfizer's patented CARs targeting BCMA offer a groundbreaking method for treating cancer. Learn about the unique ligand-binding and signaling domains for effective treatment.
Read the original article

Tags:

Previous Article

Johnson & Johnson gets grant for heart ultrasound image selection based on physi...

Next Article

Bicycle Therapeutics gets grant for high affinity binders of nectin-4 for treati...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Sage considers ways to reduce costs following FDA rejection on drug for major depression

STAT+: Sage considers ways to reduce costs following FD...

Aug 7, 2023

Sandoz partners with Samsung Bioepis to license Stelara biosimilar

Sandoz partners with Samsung Bioepis to license Stelara...

Sep 11, 2023

FDA rejects Alvotech’s Humira biosimilar for the third time

FDA rejects Alvotech’s Humira biosimilar for the third ...

Jun 29, 2023